Reading Retatrutide Evidence Well
Longer explainers on the skills needed to read this evidence for yourself — and on the questions readers ask most.
Why one trial reports two different results
TRIUMPH-1 reported both 28.3% and 25.0% for the same dose. Neither is wrong. Understanding estimands explains why — and inoculates you against a great deal of bad reporting.
Read the article →How to verify a clinical trial for yourself
A step-by-step method for checking whether a trial is real, what it actually measured, and whether its results have been reported — using free public registries and about five minutes.
Read the article →What “investigational medicine” actually means
The phrase appears in every retatrutide announcement. It carries a precise regulatory meaning that determines what may lawfully happen to the molecule — and what may not.
Read the article →
About this section
Articles are published in batches and each is written from the same primary sources as the rest of the site. We would rather publish three articles that are properly sourced than forty that are not. The editorial calendar for the remaining planned articles is maintained alongside the source register.